Related Experiment Videos
Translational proteomics: developing a predictive capacity -- a review
G E Rice1, H M Georgiou, N Ahmed
1Department of Translational Proteomics, Baker Heart Research Institute, 75 Commercial Road, Melbourne 3004, Victoria, Australia. greg.rice@baker.edu.au
Placenta
|January 26, 2006
Summary
Proteomics technologies are advancing, offering new ways to discover biomarkers and improve clinical diagnostics. This review explores proteomic tools for predictive applications, especially in women
Area of Science:
- Biochemistry
- Proteomics
- Biotechnology
Background:
- Proteomics has rapidly evolved, expanding its reach across biochemistry.
- No single technique provides complete proteomic coverage, necessitating adaptive strategies.
- Application-specific adaptations offer significant opportunities for discovery and predictive capacity development.
Purpose of the Study:
- To review proteomic technologies and their translation into predictive applications.
- To highlight opportunities for developing diagnostic and prognostic tests in reproductive biology.
- To focus on improving women's healthcare through surrogate biomarkers and clinical diagnostics.
Main Methods:
- Overview of various proteomic technologies.
- Focus on targeted proteomic approaches.
- Discussion of protein profiling strategies including affinity capture mass spectrometry and antibody arrays.
Main Results:
- Proteomic platforms can yield predictive utility in clinical and basic science.
- Solid-phase affinity capture mass spectrometry and antibody arrays are key technologies.
- These methods enable the development of new diagnostic and prognostic tests.
Conclusions:
- Proteomic technologies are crucial for developing predictive capacity.
- Targeted approaches and protein profiling offer realistic opportunities for clinical applications.
- Advancements in proteomics can significantly improve women's healthcare outcomes.